Quoin Pharmaceuticals, Ltd. (NasdaqCM: QNRX)
Health Care · Biotechnology · US
$5.11
-8.26% today · -24.2% 1Y
Quoin Pharmaceuticals, Ltd. (NasdaqCM: QNRX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $11.19M and employs 4 people.
Over the last twelve months the share price has lost 24.2%, trading between 3.25 and 41.80.
Tweenvest scores Quoin Pharmaceuticals, Ltd. across four factors: quality 26/100. Its strongest factor is quality.
QNRX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $11.19M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 1.66
- 52-week high
- $41.80
- 52-week low
- $3.25
- Avg volume (3M)
- —
- Shares outstanding
- 2.01M
- Employees
- 4
- Next earnings
- —
About Quoin Pharmaceuticals, Ltd.
Quoin Pharmaceuticals, Ltd. operates as a specialized pharmaceutical firm, concentrating its efforts on devising therapeutic solutions for rare and orphan medical conditions. Its flagship offering, QRX003, is a topical lotion specifically formulated to address Netherton Syndrome. Furthermore, the company is advancing QRX004 for the management of dystrophic epidermolysis bullosa, alongside QRX006, a prospective therapy for an additional rare dermatological ailment. The organization maintains its operational base in Ashburn, Virginia.
- ISIN
- US74907L4095
- Founded
- 2018
- Listed since
- Aug 1, 2016
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $261.36 | -1.67% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $440.60 | -0.37% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | 0.00% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $550.15 | -0.49% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $823.79 | -1.17% |
| argenx SEENXTBR: ARGX | $64.17B | €897.60 | +2.09% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $147.20 | -7.32% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.